Table 1 Clinical and histopathological characteristics at study inclusion at 1st TURB.
From: Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
Parameter | n (%) |
|---|---|
Patient data | |
Total study cohort | 171 (100) |
First diagnosis | 116 (68) |
Male patients | 139 (81) |
Median age (years) | 72 [IQR, 63–80] |
Clinical and pathological parameters | |
Staging | |
pTa | 115 (67) |
pT1 | 53 (31) |
pTis | 3 (2) |
Grading WHO1973 | |
G1 | 40 (23) |
G2 | 69 (40) |
G3 | 62 (36) |
Grading WHO2004/2016 | |
Low-grade | 82 (48) |
High-grade | 89 (52) |
Tumor diameter | |
< 30 mm | 117 (68) |
≥ 30 mm | 39 (23) |
n.a | 15 (9) |
Concomitant CIS | |
Yes | 22 (13) |
Focality | |
Multifocal | 87 (51) |
Muscle available | |
Yes | 131 (77) |
EAU NMIBC risk group | |
Low | 17 (10) |
Intermediate | 78 (46) |
High | 60 (35) |
Very high | 16 (9) |
